Obesity drug sales soar

Feb 6, 2024

This podcast explores the soaring sales of obesity drugs, specifically Eli Lilly's Mounjaro and Wegovy. It also touches on other market news such as DuPont's dividend raise and buyback, NYCB's surprising results, and Oppenheimer's sector recommendations.

Ask episode